GlobeImmune
Latest round
- Series E
Last raised
- Jan 2010
Total raised
- $119M
Investors
- 23
About GlobeImmune
GlobeImmune, Inc.Founded in 1995 and headquartered in Louisville, US, GlobeImmune, Inc. focuses on creating therapeutic vaccines that harness the immune system to combat diseases. The company has undergone strategic pivots in its operational focus over the years but has remained dedicated to immunotherapy.5 million shares at USD 10 per share.GlobeImmune develops and markets proprietary therapeutic vaccines aimed at enhancing the immune response against specific tumor antigens, particularly for oncology applications.In the most recent fiscal year of 2015, GlobeImmune reported a revenue of USD 6,457,733 and an EBITDA of USD -2,579,570.
Who invested in GlobeImmune
23 investors across 7 rounds
See all investors in GlobeImmune
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series E
Jan 19, 2010
Amount
$18M
Investors
Series D
May 14, 2009
Amount
$13M
Investors
Series C
Jul 9, 2007
Amount
$41M
Investors
Series B
Jan 10, 2006
Amount
$4.1M
Investors
Series B
Sep 15, 2005
Amount
$10M
Investors
Series B
Jun 3, 2005
Amount
$24M
Investors
Series A
Jun 18, 2003
Amount
$8M
Investors
Questions about GlobeImmune
Who invested in GlobeImmune?
GlobeImmune has 23 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GlobeImmune raised?
GlobeImmune has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did GlobeImmune last raise money?
GlobeImmune's most recent round on record is a Series E, in Jan 2010.
What does GlobeImmune do?
GlobeImmune is a pharmaceuticals company.
Where is GlobeImmune headquartered?
GlobeImmune is headquartered in Louisville, US.
Which VCs invest in companies like GlobeImmune?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at GlobeImmune's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series E
Raising like GlobeImmune? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.